Moreover, the gene expression profile of the murine CD3+ CD8+ spleenocytes also revealed that Fc-Neo-7 (Q6PT45I) significantly upregulates genes related to CD8+ T cells proliferation and metabolism without affecting their fitness and functionality, suggesting that Neo-7 (Q6PT45I) is a suitable addition to the current therapeutic space for cancer treatment. Here, CD8A is linked to cancer.